Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2021-10-07 00:00:00 ET · period of report 2021-10-04 · accession 0001567619-21-018029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-07 | 2021-10-04 | IDYA | Dillon Michael P. | SVP, CSO | S - Sale+OE | $26.36 | -1,500 | 78.8K | -2% | -$39.5K |
| D | 2021-10-07 | 2021-10-04 | IDYA | Dillon Michael P. | SVP, CSO | M - OptEx | $11.08 | +1,500 | 80.3K | +2% | +$16.6K |
| D | 2021-10-07 | 2021-10-04 | IDYA | Dillon Michael P. | SVP, CSO | M - OptEx | $0.00 | -1,500 | 23.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | S | D | 500 | $25.85 | 79,789 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $25.39 to $26.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-10-04 | S | D | 1,000 | $26.62 | 78,789 | D | — | — | (F3) This transaction was executed in multiple trades in prices ranging from $26.42 to $26.92, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-10-04 | M | A | 1,500 | $11.08 | 80,289 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-10-04 | M | D | 1,500 | $0.00 | 23,437 | D | $11.08 · — to 2029-03-13 | 1,500 Common Stock | (F4) 25% of the shares subject to the option vest on the first anniversary measured from February 19, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |